Search PubMed⌕ Search

Biomedical subjects

P Mahul

Publications and source records attributed to P Mahul.

33 records · Page 2Linked to original sources
PubMed1991

Short- and long-term prognosis, functional outcome following ICU for elderly.

Among 1532 ICU patients we analysed 295 elderly patients (19%) aged more than 70-years-old. We determined prospectively the immediate and subsequent one-year outcome with a study of the predictive value of their ICU admission parameters. Then we followed the ICU survivors over the year after discharge (1, 6, 12 months) by quality of life questionnaires. ICU mortality was 26.7%; SAPS was the only predictor of short term mortality. On ICU discharge, 216 elderly were followed at 1, 6, 12 months; the one-year cumulative mortality was 49% from ICU discharge, majority of deaths occurring over the first month. Age, previous health status and SAPS had a predictor value of one-year mortality for ICU survivors. 103 patients were alive at one year: 88% returned to home, 72% had a relatively good functional status allowing an independent life, and 82% had the same or improved functional status.

Activities of Daily Living↗
PubMed1989

Disseminated Geotrichum capitatum infection in a patient with acute myeloid leukemia.

A case of invasive Geotrichum capitatum infection is reported; a young patient had an acute leukemia for which he received a chemotherapy, and presented sepsis with blood cultures for Geotrichum capitatum, namely Dipodascus spicifer; this pathogen only described in cactus rot, is responsible for the first case of a human disseminated infection reported in literature. Then he developed a splenic and epididymic infection, with positive cultures for Geotrichum capitatum after splenectomy and castration. Treatment with amphotericin B and itraconazole was started with low minimal inhibitory concentration (0.1 microgram/ml). The patient died of massive hemoptisis. Autopsy findings demonstrated a lung, brain and kidneys seeding.

Adult↗
PubMed1987

[Erythromycin and latamoxef in the initial treatment of diffuse peritonitis with visceral failure].

In a thirty months prospective study, 61 patients treated in an Intensive Care Unit received erythromycin (E) (3 g/24 h) and latamoxef (L) (2 g/24 h) as soon as acute peritonitis was surgically confirmed. Five days later, E + L were stopped and nitro-imidazol (NI) was prescribed while searching for a possible infection. The severity of the illness was assessed by clinical study of organ failures and by use of the Simplified Acute Physiology Score (SAPS). 21 patients died (34%): among them 8 of the 19 with postoperative peritonitis. Average SAPS was 17.8 (+/- 4.1) while it was 13 in 631 ICU treated patients (mortality: 22%). Every patient needed mechanical ventilation; pré or per-operative shock has been noted in 41 (67%) and 27 had developed acute renal failure (44%). During E + L, 6 patients died because of an irreversible shock and twice the treatment was not efficient on the isolated bacteria (Pseudomonas aeruginosa, Staphylococcus). No more shock developed post-operatively. During NI, 11 secondary infections (20%) were diagnosed (bacteremia = 6, urinary tractus infection = 4, reactivated arthritis = 1). The bacteria were Streptococcus (n = 6) with Enterococcus (n = 5), Staphylococcus (n = 3) and Pseudomonas aeruginosa (n = 2): they were still respectively sensitive to ampicillin, methicillin and ticarcillin. The association E + L was clinically and biologically well tolerated.

Acute Disease↗
PubMed1986

[Hepatic diffusion of ceftriaxone].

We studied the intrahepatic diffusion of ceftriaxone, a new third generation, very potent cephalosporin with a long serum half-life. Sixteen patients had percutaneous liver biopsy for suspected liver disease or protracted fever of unknown origin. Serum samples and liver biopsy specimens were taken simultaneously. Serial determinations of ceftriaxone concentrations showed that the hepatic half-life was significantly shorter than the serum half-life. We suggest that ceftriaxone be used in higher or more closely spaced doses for the treatment of liver infections.

Adult↗
PubMedDate not supplied

[Evolutionary comparison of laboratory cardiac and infectious parameters during septic shock: about an original case].

A massive release of troponin Ic and CKMB was described in a patient during septic shock. According to experimental animal models previously described, this release of biological markers by myocardial tissue could be due to an inflammatory process of myocardial tissue during septic shock without myocardial infarction in non cardiac critically ill patients.

Aged↗
PubMedDate not supplied

[Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].

OBJECTIVES: Heparin-induced thrombocytopenia is a relatively common and potentially serious adverse complication of heparin treatment. After heparin withdrawal initiation of an alternative anticoagulant is often indicated. Org 10172 or Orgaran is a mixture of several non-heparin low molecular weight glycosaminoglycans with proven antithrombotic efficacy. Unlike low molecular weight heparins, Org 10172 has a low cross reaction rate (about 10%) with the heparin-dependent antibody. METHODS: We present nine patients with heparin induced thrombocytopenia. Org 10172 was prescribed to treat or to prevent a thromboembolic event. RESULTS: Seven patients required further parenteral anticoagulant at diagnosis of heparin-induced thrombocytopenia. Org 10172 was given at prophylactic doses for three patients with a high thrombosis risk and at therapeutic doses for four patients who presented either a venous or an arterial thrombosis related to thrombocytopenia. Two patients presented heparin-induced thrombocytopenia four to six years earlier and needed a parenteral anticoagulation treatment in a post-operative period. CONCLUSION: For the nine patients, Org 10172 was a safe and effective antithrombotic treatment. However, strict monotoring of the platelet count is absolutely mandatory during Org 10172 therapy.

Adult↗